Resveratrol — Research Evidence
The summary below was generated by an AI system (Claude) based on the studies listed. It is a synthesis tool, not a clinical opinion. Read individual studies for full context.
Resveratrol is a naturally occurring polyphenol found in red wine, grapes, blueberries, and peanuts that has attracted significant scientific attention, particularly around its potential effects on metabolic health, longevity pathways, cardiovascular function, and age-related diseases. The available evidence base includes a mix of narrative reviews, a small number of randomized controlled trials (RCTs), and meta-analyses, but the overall picture remains far from definitive. Of the 78 expert claims evaluated against this literature, only 1 was fully supported and 10 were partially supported, with 67 rated as having insufficient evidence — a striking signal that enthusiasm for resveratrol has substantially outpaced the human clinical data.
Among the more credible findings, one moderate-quality RCT examined resveratrol supplementation in patients with type 2 diabetes and reported improvements in markers of glucose regulation, inflammation, and oxidative stress, though the study size and duration limit how much can be concluded. Separate RCTs suggest potential benefits for bone mineral density in postmenopausal women, including improvements in bone turnover biomarkers when resveratrol was combined with equol. A strong-quality meta-analysis on dietary polyphenols (including resveratrol) in non-alcoholic fatty liver disease found some positive signals, and another strong meta-analysis on sleep supplements noted modest effects in its broader polyphenol analysis. Resveratrol's connection to sirtuin activation and longevity biology — popularized by David Sinclair's foundational research — is acknowledged across multiple reviews, though translating this mechanism into confirmed human health outcomes remains an open question.
The most important caveat is that a substantial portion of resveratrol's proposed benefits rest on preclinical (animal and cell-based) data that has not been reliably replicated in rigorous human trials. The human RCTs that do exist are generally small, short-term, and conducted in specific populations (e.g., diabetic adults, postmenopausal women), making it premature to generalize findings to healthy adults or other groups. Key areas such as cancer chemoprevention, ophthalmic diseases, Alzheimer's disease, endometriosis, and preeclampsia are covered only by narrative reviews without supporting clinical trial data in this evidence set. Bioavailability is a known challenge with resveratrol — it is rapidly metabolized, raising questions about what doses actually reach target tissues. The optimal dose, formulation, and duration of supplementation remain undefined.
Key findings
- ✓One moderate-quality RCT found resveratrol supplementation improved blood glucose, inflammation, and oxidative stress markers in type 2 diabetes patients, though study scale limits conclusions.
- ✓Two moderate-quality RCTs in postmenopausal women reported improvements in bone mineral density and bone turnover biomarkers with resveratrol or resveratrol-plus-equol supplementation.
- ✓A strong-quality meta-analysis on dietary polyphenols (including resveratrol) in non-alcoholic fatty liver disease found some beneficial effects, though resveratrol-specific conclusions are difficult to isolate.
- ✓Resveratrol's role in activating sirtuins and longevity-related pathways is recognized across multiple reviews, but human clinical confirmation of lifespan or healthspan benefits is lacking.
- ✓Of 78 expert claims about resveratrol evaluated against available studies, 67 were rated as having insufficient evidence — highlighting a major gap between popular claims and actual human data.
Evidence gaps
- ?There is a near-complete absence of large, long-term, well-controlled RCTs in healthy or general adult populations; most human evidence comes from small trials in specific disease groups.
- ?Many frequently cited benefits — including effects on cancer prevention, eye health, Alzheimer's disease, and cardiovascular outcomes — are supported only by narrative reviews or preclinical data, with no qualifying human trial data in this evidence set.
- ?Optimal dosing, formulation (standard vs. enhanced bioavailability), and duration of supplementation remain unestablished, and resveratrol's poor natural bioavailability is a persistent methodological challenge across studies.
Safety summary
Resveratrol is generally described as well-tolerated at typical supplemental doses in the reviewed trials, with no serious adverse events prominently reported. However, one review flags potential interactions with direct oral anticoagulants, and long-term safety data in humans is limited.
Studies (22)
Efficacy and safety of dietary polyphenol supplementation in the treatment of non-alcoholic fatty liver disease: A systematic review and meta-analysis.
Efficacy and safety of dietary polyphenol supplementation in the treatment of non-alcoholic fatty liver disease: A systematic review and meta-analysis.
Efficacy of dietary supplements on improving sleep quality: a systematic review and meta-analysis.
Efficacy of dietary supplements on improving sleep quality: a systematic review and meta-analysis.
Resveratrol supplementation efficiently improves endothelial health: A systematic review and meta-analysis of randomized controlled trials.
Resveratrol supplementation efficiently improves endothelial health: A systematic review and meta-analysis of randomized controlled trials.
Effects of Resveratrol, Curcumin and Quercetin Supplementation on Bone Metabolism-A Systematic Review.
Effects of Resveratrol, Curcumin and Quercetin Supplementation on Bone Metabolism-A Systematic Review.
Role of resveratrol supplementation in regulation of glucose hemostasis, inflammation and oxidative stress in patients with diabetes mellitus type 2: A randomized, placebo-controlled trial.
Role of resveratrol supplementation in regulation of glucose hemostasis, inflammation and oxidative stress in patients with diabetes mellitus type 2: A randomized, placebo-controlled trial.
Calorie restriction-like effects of 30 days of resveratrol supplementation on energy metabolism and metabolic profile in obese humans.
Calorie restriction-like effects of 30 days of resveratrol supplementation on energy metabolism and metabolic profile in obese humans.
Regular Supplementation With Resveratrol Improves Bone Mineral Density in Postmenopausal Women: A Randomized, Placebo-Controlled Trial.
Regular Supplementation With Resveratrol Improves Bone Mineral Density in Postmenopausal Women: A Randomized, Placebo-Controlled Trial.
Equol and Resveratrol Improve Bone Turnover Biomarkers in Postmenopausal Women: A Clinical Trial.
Equol and Resveratrol Improve Bone Turnover Biomarkers in Postmenopausal Women: A Clinical Trial.
Effects of Mediterranean Diet, Curcumin, and Resveratrol on Mild-to-Moderate Active Ulcerative Colitis: A Multicenter Randomized Clinical Trial.
Effects of Mediterranean Diet, Curcumin, and Resveratrol on Mild-to-Moderate Active Ulcerative Colitis: A Multicenter Randomized Clinical Trial.
Dietary supplements for treatment of endometriosis: A review.
Dietary supplements for treatment of endometriosis: A review.
Resveratrol and chemoprevention.
Resveratrol and chemoprevention.
Resveratrol and Its Effects on the Vascular System.
Resveratrol and Its Effects on the Vascular System.
Dietary supplements and prevention of preeclampsia.
Dietary supplements and prevention of preeclampsia.
The Clinical Significance of Drug-Food Interactions of Direct Oral Anticoagulants.
The Clinical Significance of Drug-Food Interactions of Direct Oral Anticoagulants.
Hormesis determines lifespan.
Hormesis determines lifespan.
Anti-ageing active ingredients from herbs and nutraceuticals used in traditional Chinese medicine: pharmacological mechanisms and implications for drug discovery.
Anti-ageing active ingredients from herbs and nutraceuticals used in traditional Chinese medicine: pharmacological mechanisms and implications for drug discovery.
Resveratrol and Ophthalmic Diseases.
Resveratrol and Ophthalmic Diseases.
Exploring the Efficacy and Safety of Nutritional Supplements in Alzheimer's Disease.
Exploring the Efficacy and Safety of Nutritional Supplements in Alzheimer's Disease.
Effectiveness of Medical Nutrition Therapy in the Management of Patients with Obesity and Endometriosis: from the Mediterranean Diet To the Ketogenic Diet, Through Supplementation. The Role of the Nutritionist in Clinical Management.
Effectiveness of Medical Nutrition Therapy in the Management of Patients with Obesity and Endometriosis: from the Mediterranean Diet To the Ketogenic Diet, Through Supplementation. The Role of the Nutritionist in Clinical Management.
Resveratrol (RV): A pharmacological review and call for further research.
Resveratrol (RV): A pharmacological review and call for further research.